Zimbabwe is a country defined by a history of heavy-handed land seizures.
After a lifetime of problems, a glimmer of hope began to shine on the family
Technological advance has revolutionized epilepsy management recently. Herein, we review some recent developments. Perampanel (FDA-approved 2012) is a promising new class of AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-antagonist anti-seizure therapy. Meanwhile, a millennia-old remedy for epilepsy, cannabis, is staging a comeback with recent legal and social permissiveness accelerating research into this use.
The old saying goes that good things come to those who wait, so we hope that the wait is almost over